-
Connecticut Judge Adds $7.5 Million Punitive Damages to Mesothelioma Verdict
Last May, A Connecticut jury ordered talc supplier R. T. Vanderbilt to pay $15 million to the family of mesothelioma victim Nicholas Barone after they found him liable for the man’s death. This week, the judge overseeing the case added another $7.5 million in punitive damages to the amount the company owes.
-
Asbestos Contractor Puts Neighborhood at Risk for Mesothelioma
An asbestos contractor in Jefferson County, Colorado, has been convicted of multiple crimes after his negligent, fraudulent practices put his employees, a client, and an entire neighborhood at risk of future mesothelioma diagnoses. The man improperly removed and dumped asbestos, charging an elderly man $70,000 for the substandard work.
-
Successful Use of Immunotherapy Reported in Peritoneal Mesothelioma Patient
A case study published in the journal Frontiers in Oncology demonstrates that nivolumab and ipilimumab can provide a sustained positive response in patients with malignant peritoneal mesothelioma.
-
Study Highlights Benefits of Heated Chemotherapy for Pleural Mesothelioma
Malignant mesothelioma is a rare and deadly form of cancer caused by exposure to asbestos. The disease can appear in the pleural cavity, the peritoneal cavity, and extremely rarely in the pericardial cavity. Administering heated chemotherapy after tumor removal surgery has proven to be extremely effective in patients with peritoneal mesothelioma, and now researchers say
-
Ovarian Cancer and Mesothelioma Talc Claims Spread to UK
Attorneys representing mesothelioma and ovarian cancer victims in the United Kingdom have announced that they’ve begun legal action against U.S. cosmetic and pharmaceutical giant Johnson & Johnson. They accuse the company of negligence in having exposed their clients to asbestos in the company’s iconic baby powder and talcum powder products.
-
Mesothelioma Treatment Center Marks 20th Year of Precision Medicine Treatment
The Roswell Park Comprehensive Cancer Center is one of the country’s leading treatment centers for malignant mesothelioma. Among the many innovative discoveries that have helped the center treat patients with lung cancers is the discovery of the EGFR gene mutation. The center is marking the 20th anniversary of that breakthrough and the development of several targeted
-
Study Tests Impact of Radioimmunoconjugate in Malignant Mesothelioma
A study published this month in the journal Scientific Reports details research into a promising new therapeutic target for treating malignant mesothelioma. Researchers investigated intracavitary administration of a radioimmunoconjugate in laboratory animals and found it may offer an important new method for improving patient outcomes.
-
European Agency Signals Approval for Keytruda for First-line Mesothelioma Treatment
Weeks after the U.S. Food and Drug Administration (FDA) approved pembrolizumab (Keytruda) plus pemetrexed and platinum-based chemotherapy for the frontline treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma, the European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) issued a similar endorsement, signaling its approval of the drug for use
-
Mesothelioma Victims Wait as Judge Is Asked to Reject J&J Chapter 11 Talc Bankruptcy Document
It’s been years since Johnson & Johnson first responded to malignant mesothelioma and ovarian cancer claims by attempting a controversial bankruptcy strategy called the Texas Two Step. After multiple rejections of the company’s settlement plan, a Texas judge recently allowed a third filing and reorganization plan to be submitted in his court. But now that
-
Jury Awards $3.45 Million to Millwright Stricken with Mesothelioma
James Katcham died of malignant mesothelioma after having worked as a millwright at the DuPont Spruance plant in Chesterfield, Virginia. His widow Patricia filed a personal injury lawsuit naming several companies she blamed for his occupational exposure to asbestos. On October 9th, a Newport News, Va. Circuit Court jury ordered the sole remaining defendant, John
-
Study Highlights Gut Bacteria’s Impact on Mesothelioma Treatment
Medical professionals in the United Kingdom are investigating whether mesothelioma patients’ intestinal ecosystem of mesothelioma patients plays a role in their response to immunotherapy. In preliminary investigations, researchers from the University of Leicester sequenced the genetic code of patients’ gut bacteria to determine whether there was a relationship between the two.
-
Veteran’s Day May Feel Different for Vets with Mesothelioma
Whether they volunteered or were drafted, and no matter when they served, America’s veterans had a strong sense of the risks they faced — but none of them anticipated that their service would put them at risk for malignant mesothelioma or other asbestos-related diseases. Today is Veteran’s Day – the day the nation set aside
-
Pennsylvania Superior Court Sides with Mesothelioma Widow in Insurance Fight
Ronald L. Suman was diagnosed with malignant mesothelioma as a result of his exposure to asbestos dust and fibers during his employment with Penelec between 1975 and 1996. After he died, his wife filed an amended complaint for wrongful death on behalf of herself and their children. Though the victim’s insurer argued it was not
-
Mayo Clinic Announces New Test for Mesothelioma Detection
This week, researchers from the Mayo Clinic announced a new testing protocol that may significantly improve early detection of malignant mesothelioma. According to medical oncologist Dr. Aaron Mansfield of the Center for Individualized Medicine, the innovative approach relies on detecting chromosomal rearrangements that typically occur in mesothelioma cancer cells’ DNA.
-
Researchers Turn to Capsaicin to Treat Mesothelioma
Could the chemical that makes peppers hot help control malignant mesothelioma tumors? That’s what researchers from the Sbarro Health Research Organization (SHRO) set out to study, and their results were very encouraging.
-
Shipyard Worker’s Mesothelioma Lawsuit Cites 30 Years of Asbestos Exposure
Robert Stephen Sentilles is pursuing justice against multiple companies that he blames for his malignant mesothelioma. In his lawsuit, which points primarily to his former employer, Avondale Shipyards, he cites numerous products made with the toxic material that he worked with over the years.
-
Lung Cancer Plaintiff’s Asbestos Claim Against Oil Company to Continue
Mallory Ware worked as a welder for decades, and after being diagnosed with asbestos-related lung cancer, he filed a lawsuit in state court against several defendants. All of the companies named were accused of negligence, but some were accused of premises liability, and others were accused of product liability. Though Marathon Oil Company objected to
-
Mesothelioma Fears Rise as Asbestos-Contaminated Talc Recall Expands
Asbestos-contaminated talc has been blamed for thousands of cases of malignant mesothelioma and ovarian cancer. While most of the attention has been paid to brand-name products like Johnson & Johnson’s Baby Powder, that company discontinued its use of talc. Others continue using it, including the Dynacare Baby Powder distributed across the nation and sold online
-
Multicenter Group Compares Real-World Mesothelioma Outcomes to Clinical Study
There is sometimes a significant gap between the results of clinical trials and what physicians see in the real world, and that can lead to unexpected outcomes. To assess whether the use of ipilimumab and nivolumab in mesothelioma patients would deliver what was indicated in the renowned CheckMate 743 study, a multicenter group of physicians
-
Department of Justice Intervenes in J&J Talc Bankruptcy
There are tens of thousands of mesothelioma and ovarian cancer victims who have filed claims against Johnson & Johnson, claiming that asbestos contaminating the talc in the iconic company’s baby powder was the cause of their illness. Faced with a rising number of multi-million-dollar verdicts, the company has repeatedly attempted a controversial strategy of filing
